专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US5648353A Quinazolines and phthalazines having adenosine uptake inhibitor activity 失效
标题翻译：喹唑啉和具有腺苷摄取抑制剂活性的酞嗪酮
公开(公告)号：US5648353A
公开(公告)日：1997-07-15
申请号：US446235
申请日：1995-05-22
申请人： Shigeki Fujiwara , Daisuke Machii , Haruki Takai , Hiromi Nonaka , Hiroshi Kase , Kozo Yao , Michiyo Kawakage , Hideaki Kusaka , Akira Karasawa
发明人： Shigeki Fujiwara , Daisuke Machii , Haruki Takai , Hiromi Nonaka , Hiroshi Kase , Kozo Yao , Michiyo Kawakage , Hideaki Kusaka , Akira Karasawa
IPC分类号： C07D401/14 , C07D491/04 , C07D401/04 , A61K31/445 , A61K31/50 , A61K31/505
CPC分类号： C07D401/14 , C07D491/04
摘要： The present invention relates to an adenosine uptake inhibitor and an agent for the myocardium protection or the prevention or treatment of inflammatory edema, comprising a 1,2,3,4-tetrahydro-2,4-dioxoquinazoline derivative represented by formula (I): ##STR1## wherein R.sup.1 represents hydrogen, substituted or unsubstituted lower alkyl, alkenyl, or substituted or unsubstituted aralkyl; R.sup.2, R.sup.3, R.sup.4, and R.sup.5 independently represent hydrogen, halogen, amino, mono- or di(lower alkyl)amino, lower alkanoylamino, nitro, cyano, substituted or unsubstituted lower alkyl, hydroxy, lower alkoxy, lower alkylthio, carboxy, lower alkoxycarbonyl, lower alkanoyl, aralkyloxy, or lower alkanoyloxy; R.sup.6, R.sup.7, R.sup.8, and R.sup.9 independently represent hydrogen, hydroxy, substituted or unsubstituted lower alkoxy, or aralkyloxy, or any adjoining two of them are combined to form methylenedioxy; R.sup.10 represents hydrogen or lower alkyl; and Y and Z independently represent N or C--R.sup.11 (wherein R.sup.11 represents hydrogen, substituted or unsubstituted lower alkyl, or halogen),or a pharmaceutically acceptable salt thereof as an active ingredient.
摘要翻译：本发明涉及腺苷摄取抑制剂和用于心肌保护或预防或治疗炎性水肿的药剂，其包含由式（I）表示的1,2,3,4-四氢-2,4-二氧代喹唑啉衍生物：（I）其中R 1表示氢，取代或未取代的低级烷基，烯基或取代或未取代的芳烷基; R2，R3，R4和R5独立地表示氢，卤素，氨基，一或二（低级烷基）氨基，低级烷酰基氨基，硝基，氰基，取代或未取代的低级烷基，羟基，低级烷氧基，低级烷硫基，羧基，低级烷氧基羰基，低级烷酰基，芳烷氧基或低级烷酰氧基; R 6，R 7，R 8和R 9独立地表示氢，羟基，取代或未取代的低级烷氧基或芳烷氧基，或者它们中的任何相邻的两个被结合形成亚甲二氧基; R 10表示氢或低级烷基; 并且Y和Z独立地表示作为活性成分的N或C-R11（其中R11表示氢，取代或未取代的低级烷基或卤素）或其药学上可接受的盐。

2. 发明申请

US20060046992A1 HETEROBICYCLIC COMPOUNDS 审中-公开
标题翻译：杂环化合物
公开(公告)号：US20060046992A1
公开(公告)日：2006-03-02
申请号：US10519630
申请日：2003-06-25
申请人： Daisuke Machii , Koji Suzuki , Tsutomu Matsumura , Hitoshi Arai , Miho Iwase , Hiroshi Yano , Satoshi Nakanishi , Fumiko Ogino , Kotaro Takasaki , Hideaki Kusaka
发明人： Daisuke Machii , Koji Suzuki , Tsutomu Matsumura , Hitoshi Arai , Miho Iwase , Hiroshi Yano , Satoshi Nakanishi , Fumiko Ogino , Kotaro Takasaki , Hideaki Kusaka
IPC分类号： A61K31/519 , C07D487/04
CPC分类号： C07D471/04 , A61K31/437 , A61K31/445 , A61K31/4453 , A61K31/4545 , A61K31/496 , A61K31/519 , A61K31/5377 , A61K31/55 , C07D487/04
摘要： The present invention provides a compound represented by formula (I): [wherein X—Y-Z represents R5N—C═O (wherein R5 represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aralkyl, substituted or unsubstituted lower alkenyl, or substituted or unsubstituted lower alkynyl), etc; R1 and R2 may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, etc; and R3 and R4 may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, etc], or a pharmaceutically acceptable salt thereof.
摘要翻译：本发明提供由式（I）表示的化合物：[其中XYZ表示R 5 NCO（其中R 5表示氢原子，取代或未取代的低级烷基，取代的或未取代的芳烷基，取代或未取代的低级烯基，或取代或未取代的低级炔基）等; R 1和R 2可以相同或不同，各自表示氢原子，取代或未取代的低级烷基等; R 3和R 4可以相同或不同，各自表示氢原子，取代或未取代的低级烷基等]或其药学上可接受的盐。

3. 发明授权

US5698560A Imidazoquinazoline derivatives 失效
标题翻译：咪唑喹唑啉衍生物
公开(公告)号：US5698560A
公开(公告)日：1997-12-16
申请号：US727598
申请日：1996-10-23
申请人： Yasuo Onoda , Shin-ichi Sasaki , Daisuke Machii , Haruki Takai , Tetsuji Ohno , Koji Yamada , Michio Ichimura , Hiroshi Kase
发明人： Yasuo Onoda , Shin-ichi Sasaki , Daisuke Machii , Haruki Takai , Tetsuji Ohno , Koji Yamada , Michio Ichimura , Hiroshi Kase
IPC分类号： C07D487/04 , A61K31/505 , A61K31/535 , C07D417/02 , C07D487/02
CPC分类号： C07D487/04
摘要： The present invention relates to imidazoquinazoline derivatives represented by formula (I): ##STR1## wherein R.sup.1 represents hydrogen, substituted or unsubstituted lower alkyl, cycloalkyl, lower alkenyl, substituted or unsubstituted aralkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroarylalkyl, or substituted or unsubstituted heteroaryl, R.sup.2 and R.sup.3 represent independently hydrogen, substituted or unsubstituted lower alkyl, substituted or unsubstituted aralkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroarylalkyl, or substituted or unsubstituted heteroaryl, or R.sup.2 and R.sup.3 are combined to represent a heterocyclic group containing a nitrogen atom, R.sup.4 represents hydrogen or substituted or unsubstituted lower alkyl, X represents O or S, Y represents a single bond or O, n represents 0, 1, 2, or 3, and pharmaceutically acceptable salts thereof.
摘要翻译： PCT No.PCT / JP96 / 00497 Sec。 371日期：1996年10月23日 102（e）日期1996年10月23日PCT 1996年3月1日PCT公布。第WO96 / 26940号公报日本1996年9月6日本发明涉及由式（I）表示的咪唑并喹唑啉衍生物：其中R1表示氢，取代或未取代的低级烷基，环烷基，低级烯基，取代或未取代的芳烷基，取代或未取代的芳基取代或未取代的芳基，取代或未取代的杂芳基，或取代或未取代的杂芳基，或者取代或未取代的杂芳基，或者取代或未取代的杂芳基，或R 2和R 3 合并表示含有氮原子的杂环基，R4表示氢或取代或未取代的低级烷基，X表示O或S，Y表示单键或O，n表示0,1,2或3，以及药学上可接受的的盐。

4. 发明授权

US5605900A Benzotriazines having adenosine uptake inhibitor activity 失效
标题翻译：具有腺苷摄取抑制剂活性的苯并三嗪
公开(公告)号：US5605900A
公开(公告)日：1997-02-25
申请号：US430227
申请日：1995-04-28
申请人： Shigeki Fujiwara , Daisuke Machii , Haruki Takai , Hiromi Nonaka , Hiroshi Kase , Kozo Yao , Michiyo Kawakage , Hideaki Kusaka , Akira Karasawa
发明人： Shigeki Fujiwara , Daisuke Machii , Haruki Takai , Hiromi Nonaka , Hiroshi Kase , Kozo Yao , Michiyo Kawakage , Hideaki Kusaka , Akira Karasawa
IPC分类号： C07D401/14 , C07D491/04 , C07D401/04 , A61K31/445 , A61K31/50 , A61K31/53
CPC分类号： C07D401/14 , C07D491/04
摘要： The present invention relates to an adenosine uptake inhibitor and an agent for the myocardium protection or the prevention or treatment of inflammatory edema, comprising a 1,2,3,4-tetrahydro-2,4-dioxoquinazoline derivative represented by formula (I): ##STR1## wherein R.sup.1 represents hydrogen, substituted or unsubstituted lower alkyl, alkenyl, or substituted or unsubstituted aralkyl; R.sup.2, R.sup.3, R.sup.4, and R.sup.5 independently represent hydrogen, halogen, amino, mono- or di(lower alkyl)amino, lower alkanoylamino, nitro, cyano, substituted or unsubstituted lower alkyl, hydroxy, lower alkoxy, lower alkylthio, carboxy, lower alkoxycarbonyl, lower alkanoyl, aralkyloxy, or lower alkanoyloxy; R.sup.6, R.sup.7, R.sup.8, and R.sup.9 independently represent hydrogen, hydroxy, substituted or unsubstituted lower alkoxy, or aralkyloxy, or any adjoining two of them are combined to form methylenedioxy; R.sup.10 represents hydrogen or lower alkyl; and Y and Z independently represent N or C-R.sup.11 (wherein R.sup.11 represents hydrogen, substituted or unsubstituted lower alkyl, or halogen),or a pharmaceutically acceptable salt thereof as an active ingredient.
摘要翻译：本发明涉及腺苷摄取抑制剂和用于心肌保护或预防或治疗炎性水肿的药剂，其包含由式（I）表示的1,2,3,4-四氢-2,4-二氧代喹唑啉衍生物：（I）其中R 1表示氢，取代或未取代的低级烷基，烯基或取代或未取代的芳烷基; R2，R3，R4和R5独立地表示氢，卤素，氨基，一或二（低级烷基）氨基，低级烷酰基氨基，硝基，氰基，取代或未取代的低级烷基，羟基，低级烷氧基，低级烷硫基，羧基，低级烷氧基羰基，低级烷酰基，芳烷氧基或低级烷酰氧基; R 6，R 7，R 8和R 9独立地表示氢，羟基，取代或未取代的低级烷氧基或芳烷氧基，或者它们中的任何相邻的两个被结合形成亚甲二氧基; R 10表示氢或低级烷基; 并且Y和Z独立地表示作为活性成分的N或C-R11（其中R11表示氢，取代或未取代的低级烷基或卤素）或其药学上可接受的盐。

6. 发明授权

US5891902A Indole derivatives 失效
标题翻译：吲哚衍生物
公开(公告)号：US5891902A
公开(公告)日：1999-04-06
申请号：US676177
申请日：1996-07-15
申请人： Daisuke Machii , Haruki Takai , Nobuo Kosaka , Hisakatsu Seo , Tomomi Sugiyama , Joji Nakamura , Hiroyuki Ishida , Katsushige Gomi , Soichiro Sato , Masako Uchii , Koji Suzuki
发明人： Daisuke Machii , Haruki Takai , Nobuo Kosaka , Hisakatsu Seo , Tomomi Sugiyama , Joji Nakamura , Hiroyuki Ishida , Katsushige Gomi , Soichiro Sato , Masako Uchii , Koji Suzuki
IPC分类号： C07D209/30 , C07D209/42 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D521/00 , A61K31/40 , C07D209/12 , C07D209/14
CPC分类号： C07D231/12 , C07D209/30 , C07D209/42 , C07D233/56 , C07D249/08 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12
摘要： The present invention relates to indole derivatives represented by formula (I): ##STR1## wherein R.sup.1 and R.sup.2 independently represent hydrogen, lower alkyl, hydroxy, lower alkoxy, halogen, --O--(CH.sub.2).sub.n --OR.sup.5, or ##STR2## R.sup.3 represents hydrogen, lower alkyl, or ##STR3## R.sup.4 represents hydroxy, lower alkoxy, substituted or unsubstituted aryloxy, or --NR.sup.10 R.sup.11, and X represents CO or SO.sub.2, with the proviso that when R.sup.3 is hydrogen or lower alkyl, and X is CO, R.sup.4 is --NR.sup.10 R.sup.11, or pharmaceutically acceptable salts thereof.
摘要翻译：本发明涉及由式（I）表示的吲哚衍生物：其中R1和R2独立地表示氢，低级烷基，羟基，低级烷氧基，卤素，-O-（CH2）n-OR5或 R 3表示氢，低级烷基或R 4表示羟基，低级烷氧基，取代或未取代的芳氧基或-NR 10 R 11，X表示CO或SO 2，条件是当R 3为氢或低级烷基时，X 是CO，R 4是-NR 10 R 11，或其药学上可接受的盐。

7. 发明授权

US5658917A Isoquinolines having adenosine uptake inhibitor activity 失效
标题翻译：具有腺苷摄取抑制剂活性的异喹啉
公开(公告)号：US5658917A
公开(公告)日：1997-08-19
申请号：US430234
申请日：1995-04-28
申请人： Shigeki Fujiwara , Daisuke Machii , Haruki Takai , Hiromi Nonaka , Hiroshi Kase , Kozo Yao , Michiyo Kawakage , Hideaki Kusaka , Akira Karasawa
发明人： Shigeki Fujiwara , Daisuke Machii , Haruki Takai , Hiromi Nonaka , Hiroshi Kase , Kozo Yao , Michiyo Kawakage , Hideaki Kusaka , Akira Karasawa
IPC分类号： C07D401/14 , C07D491/04 , A61K31/445 , A61K31/50 , A61K31/505
CPC分类号： C07D401/14 , C07D491/04
摘要： The present invention relates to an adenosine uptake inhibitor and an agent for the myocardium protection or the prevention or treatment of inflammatory edema, comprising a 1,2,3,4-tetrahydro-2,4-dioxoquinazoline derivative represented by formula (I): ##STR1## wherein R.sup.1 represents hydrogen, substituted or unsubstituted lower alkyl, alkenyl, or substituted or unsubstituted aralkyl; R.sup.2, R.sup.3, R.sup.4, and R.sup.5 independently represent hydrogen, halogen, amino, mono- or di(lower alkyl)amino, lower alkanoylamino, nitro, cyano, substituted or unsubstituted lower alkyl, hydroxy, lower alkoxy, lower alkylthio, carboxy, lower alkoxycarbonyl, lower alkanoyl, aralkyloxy, or lower alkanoyloxy; R.sup.6, R.sup.7, R.sup.8, and R.sup.9 independently represent hydrogen, hydroxy, substituted or unsubstituted lower alkoxy, or aralkyloxy, or any adjoining two of them are combined to form methylenedioxy; R.sup.10 represents hydrogen or lower alkyl; and Y and Z independently represent N or C--R.sup.11 (wherein R.sup.11 represents hydrogen, substituted or unsubstituted lower alkyl, or halogen),or a pharmaceutically acceptable salt thereof as an active ingredient.
摘要翻译：本发明涉及腺苷摄取抑制剂和用于心肌保护或预防或治疗炎性水肿的药剂，其包含由式（I）表示的1,2,3,4-四氢-2,4-二氧代喹唑啉衍生物：（I）其中R 1表示氢，取代或未取代的低级烷基，烯基或取代或未取代的芳烷基; R2，R3，R4和R5独立地表示氢，卤素，氨基，一或二（低级烷基）氨基，低级烷酰基氨基，硝基，氰基，取代或未取代的低级烷基，羟基，低级烷氧基，低级烷硫基，羧基，低级烷氧基羰基，低级烷酰基，芳烷氧基或低级烷酰氧基; R 6，R 7，R 8和R 9独立地表示氢，羟基，取代或未取代的低级烷氧基或芳烷氧基，或者它们中的任何相邻的两个被结合形成亚甲二氧基; R 10表示氢或低级烷基; 并且Y和Z独立地表示作为活性成分的N或C-R11（其中R11表示氢，取代或未取代的低级烷基或卤素）或其药学上可接受的盐。

8. 发明授权

US5661147A Imidazoquinazoline derivatives 失效
标题翻译：咪唑喹唑啉衍生物
公开(公告)号：US5661147A
公开(公告)日：1997-08-26
申请号：US424274
申请日：1995-04-26
申请人： Daisuke Machii , Kenji Matsuno , Iwao Kinoshita , Yuji Nomoto , Haruki Takai , Tetsuji Ohno , Ken Nagashima , Tomoko Ishikawa , Koji Yamada , Michio Ichimura , Hiroshi Kase
发明人： Daisuke Machii , Kenji Matsuno , Iwao Kinoshita , Yuji Nomoto , Haruki Takai , Tetsuji Ohno , Ken Nagashima , Tomoko Ishikawa , Koji Yamada , Michio Ichimura , Hiroshi Kase
IPC分类号： C07D487/04 , C07D417/04 , A61K31/505 , C07D243/08 , C07D413/04
CPC分类号： C07D487/04
摘要： The present invention relates to imidazoquinazoline derivatives represented by the general formula (I): ##STR1## or pharmacologically acceptable salts thereof. The compounds of the present invention have strong and selective cGMP-specific PDE inhibitory activity and are useful for treating or ameliorating cardiovascular diseases such as thrombosis, angina pectoris, hypertension, arterial sclerosis and the like, as well as asthma and the like.
摘要翻译： PCT No.PCT / JP94 / 01456 Sec。 371日期1995年04月26日 102（e）日期1995年4月26日PCT 1994年9月2日PCT PCT。出版物WO95 / 06648 日期：1995年3月9日本发明涉及由通式（I）表示的咪唑并喹唑啉衍生物或其药理学上可接受的盐。本发明的化合物具有强的选择性cGMP特异性PDE抑制活性，可用于治疗或改善心血管疾病如血栓形成，心绞痛，高血压，动脉硬化等，以及哮喘等。

9. 发明授权

US5624926A Piperidinyl-dioxoquinazolines as adenosine reuptake inhibitors 失效
标题翻译：哌啶基 - 二氧喹唑啉作为腺苷再摄取抑制剂
公开(公告)号：US5624926A
公开(公告)日：1997-04-29
申请号：US318876
申请日：1994-10-17
申请人： Shigeki Fujiwara , Daisuke Machii , Haruki Takai , Hiromi Nonaka , Hiroshi Kase , Kozo Yao , Michiyo Kawakage , Hideaki Kusaka , Akira Karasawa
发明人： Shigeki Fujiwara , Daisuke Machii , Haruki Takai , Hiromi Nonaka , Hiroshi Kase , Kozo Yao , Michiyo Kawakage , Hideaki Kusaka , Akira Karasawa
IPC分类号： C07D401/14 , C07D491/04 , A61K31/50 , A61K31/505
CPC分类号： C07D401/14 , C07D491/04
摘要： The present invention relates to an adenosine uptake inhibitor and an agent for the myocardium protection or the prevention or treatment of inflammatory edema, comprising a 1,2,3,4-tetrahydro-2,4-dioxoquinazoline derivative represented by formula (I): ##STR1## wherein R.sup.1 represents hydrogen, substituted or unsubstituted lower alkyl, alkenyl, or substituted or unsubstituted aralkyl; R.sup.2, R.sup.3, R.sup.4, and R.sup.5 independently represent hydrogen, halogen, amino, mono- or di(lower alkyl)amino, lower alkanoylamino, nitro, cyano, substituted or unsubstituted lower alkyl, hydroxy, lower alkoxy, lower alkylthio, carboxy, lower alkoxycarbonyl, lower alkanoyl, aralkyloxy, or lower alkanoyloxy; R.sup.6, R.sup.7, R.sup.8, and R.sup.9 independently represent hydrogen, hydroxy, substituted or unsubstituted lower alkoxy, or aralkyloxy, or any adjoining two of them are combined to form methylenedioxy; R.sup.10 represents hydrogen or lower alkyl; and Y and Z independently represent N or C--R.sup.11 (wherein R.sup.11 represents hydrogen, substituted or unsubstituted lower alkyl, or halogen),or a pharmaceutically acceptable salt thereof as an active ingredient.
摘要翻译： PCT No.PCT / JP94 / 00229 Sec。 371日期：1994年10月17日 102（e）日期1994年10月17日PCT 1994年2月16日PCT PCT。 WO94 / 19342 PCT公开号日期：1994年9月1日本发明涉及一种腺苷摄取抑制剂和用于心肌保护或预防或治疗炎性水肿的药剂，其包含1,2,3,4-四氢-2,4-二氧代喹唑啉衍生物式（I）：其中R 1表示氢，取代或未取代的低级烷基，烯基或取代或未取代的芳烷基; R2，R3，R4和R5独立地表示氢，卤素，氨基，一或二（低级烷基）氨基，低级烷酰基氨基，硝基，氰基，取代或未取代的低级烷基，羟基，低级烷氧基，低级烷硫基，羧基，低级烷氧基羰基，低级烷酰基，芳烷氧基或低级烷酰氧基; R 6，R 7，R 8和R 9独立地表示氢，羟基，取代或未取代的低级烷氧基或芳烷氧基，或者它们中的任何相邻的两个被结合形成亚甲二氧基; R 10表示氢或低级烷基; 并且Y和Z独立地表示作为活性成分的N或C-R11（其中R11表示氢，取代或未取代的低级烷基或卤素）或其药学上可接受的盐。

10. 发明授权

US5413997A Triphenylmethane derivatives 失效
标题翻译：三苯甲烷衍生物
公开(公告)号：US5413997A
公开(公告)日：1995-05-09
申请号：US7104
申请日：1993-01-21
申请人： Iwao Kinoshita , Daisuke Machii , Yasuo Onoda , Haruki Takai , Nobuo Kosaka , Katsuichi Shuto , Katsushige Gomi , Makoto Morimoto , Akio Ishii
发明人： Iwao Kinoshita , Daisuke Machii , Yasuo Onoda , Haruki Takai , Nobuo Kosaka , Katsuichi Shuto , Katsushige Gomi , Makoto Morimoto , Akio Ishii
IPC分类号： A61K31/09 , A61K31/135 , A61K31/165 , A61K31/365 , A61K31/38 , A61K31/381 , A61K31/395 , A61K31/40 , A61K31/425 , A61K31/426 , A61K31/428 , A61K31/44 , A61K31/4406 , A61K31/4427 , A61K31/47 , A61K31/472 , A61P3/00 , A61P9/00 , A61P19/10 , C07C217/58 , C07C217/60 , C07C233/11 , C07C233/25 , C07C233/26 , C07C233/29 , C07C233/60 , C07C233/65 , C07C233/75 , C07C235/44 , C07C235/46 , C07C235/54 , C07C235/56 , C07C235/64 , C07C237/32 , C07C237/40 , C07C323/42 , C07D207/09 , C07D211/58 , C07D213/74 , C07D213/75 , C07D213/82 , C07D215/06 , C07D217/04 , C07D221/20 , C07D223/20 , C07D225/08 , C07D277/20 , C07D277/44 , C07D277/46 , C07D277/82 , C07D295/096 , C07D295/10 , C07D295/112 , C07D295/13 , C07D295/135 , C07D295/192 , C07D295/205 , C07D307/00 , C07D311/00 , C07D333/20 , C07D333/38 , C07D401/04 , C07D413/04 , A01N43/00 , A01N33/02 , A01N43/40 , A01N43/62 , C07C43/21 , C07C211/45 , C07C229/42 , C07D215/28 , C07D215/36 , C07D215/38
CPC分类号： C07D213/75 , C07C217/58 , C07C217/60 , C07C233/25 , C07C233/26 , C07C233/29 , C07C233/60 , C07C233/75 , C07C235/44 , C07C235/56 , C07C235/64 , C07C237/40 , C07C323/42 , C07D211/58 , C07D213/74 , C07D215/06 , C07D217/04 , C07D221/20 , C07D225/08 , C07D277/46 , C07D277/82 , C07D295/096 , C07D295/112 , C07D295/13 , C07D295/135 , C07D295/192 , C07D295/205 , C07D307/00 , C07D333/20 , C07D333/38 , C07D413/04 , C07C2101/02 , C07C2101/08 , C07C2101/18 , C07C2102/08 , C07C2102/42 , C07C2103/18 , C07C2103/74
摘要： A triphenylmethane derivative represented by the following general formula: ##STR1## exhibits bone absorption inhibiting effects and is useful as a medicament for treating osteoporosis.
摘要翻译：由以下通式表示的三苯甲烷衍生物：表现出骨吸收抑制作用，可用作治疗骨质疏松症的药物。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式